Pancreatic cancer gains with four drug combo shown
In a French Canadian trial nearly 500 patients with operable pancreatic tumors received the four drug regimen folfirinox or Gemzar. After three years folfirinox yielded about 40 percent disease-free status and two thirds survival versus 20 percent and half with Gemzar.
MENTIONED IN THIS ARTICLE
Chicago
Thierry Conroy
Cancer Institute of Lorraine
Vandoeuvre-les-Nancy
France
American Society of Clinical Oncology
Richard Schilsky
United States
Andrew
Gemzar
Schilsky
Also Mentioned on This Page
AccuWeather
Pee Almanac Lorain County
Avon Lake
Cleveland
Sandusky
Bellevue
Lake Erie
A Huron
Norwalk
Willard
Shiloh
Lora
de Elyria
Grafton
Lakewood
Brunswick Fair
Parma
New London
Wellington
Bailey Lakes
Lodi
Oberlin
Medina
Wadswort
Maple Heights
Creston
Doylestown
Barberton
Tom
Aspen
Ganeun
Daytona Beach
Honolulu
Mac Jacksonville
Key West
Las Vegas
Miami
Montego Bay
Myrtle Beach
Nassau
Oranjestad
Aruba
Orlando
Palm Springs
Puerto Vallarta
Punta Cana
Rio de Janeiro
San Juan
Baghdad
Beijing
Beirut
Ums
Aos Berlin
Buenos Aires
Cairo
Ral
Calgary
Ws Dublin
Hong Kong
Sh Jerusalem
Lisbon
London
Pe Madrid
St c
Seget
Mexico City
Montreal
Moscow
New Delhi
Paris
Rome
Seoul
Singapore
Sydney
Tokyo
Toronto
Warsaw
Gee
AccuWeather, Inc
City
City HI Lo
Atlanta
Memphis
Atlantic City
Milwaukee
Baltimore
Minneapolis
Birmingham
Nashville
Boise
New Orleans
Boston
New York City
Charleston
Norfolk
Oklahoma City
Omaha
Cincinnati
Philadelphia
St. Louis
Erie
Salt Lake City
Fairbanks
San Diego
Houston
San Francisco
Huntington
Santa Fe
Indianapolis
Seattle
Kansas City
Toledo
Little Rock
Topeka
Los Angeles
Tucson
Louisville
Washington, DC
USC
NIH
Scadem A
Ceretnet
Vni
Academy Court
Elyria
West Ridge Road
113
Ercliving.com
Absolute Hair CO
Dee Ann Stawicki
Lilly’s
North Ridgeville
Abbe Rd
Ohio
Elmcroft ™ OF
Lorain
Elmcroft
Dad
Cooper Foster Park
East Ave
Billbakersinc.com
Aewicahrese
Wee Advantage Life Insurance
Lements
Cary
Jack Sito Insurance
Windstream